跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard
Approved
STANDARD
REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
fec750c023517d5a
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
fec750c023517d5a
Product Name
REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard
Artg Id
461900
Artg Name
REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2024-11-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
fec750c023517d5a
Type
Standard
Back to TGA Approvals
REXADEV denosumab (rch) 60mg/1mL solution for injection prefilled syringe with automatic needle guard - TGA Drug Approval Details
